Global transcriptional profiling reveals similarities and differences between human stem cell-derived cardiomyocyte clusters and heart tissue

Physiological Genomics

Volumn 44, Issue 4, 2012, Pages 245-258

  Synnergren, Jane ^a,b   Améen, Caroline ^c   Jansson, Andreas ^a   Sartipy, Peter ^c  

^a UNIVERSITY OF SKÖVDE   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c Cellartis   (Sweden)

Author keywords

Ca 2+ handling; Cardiomyocytes; Differentiation; Gene expression; Human embryonic stem cells; Ion channels

Indexed keywords

CALCIUM ION; ION CHANNEL;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYONIC STEM CELL; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ENGINEERING; HEART; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; MICROARRAY ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; REGENERATIVE MEDICINE; TOXICITY TESTING;

ADULT; CALCIUM-BINDING PROTEINS; CALSEQUESTRIN; CARRIER PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; EMBRYONIC STEM CELLS; FEMALE; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MALE; MEMBRANE PROTEINS; MIXED FUNCTION OXYGENASES; MUSCLE PROTEINS; MYOCARDIUM; MYOCYTES, CARDIAC; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SODIUM-CALCIUM EXCHANGER; YOUNG ADULT;

EID: 84857762746     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00118.2011     Document Type: Article

References (45)

1. Ameen C, Strehl R, Björquist P, Lindahl A, Hyllner J, Sartipy P. Human embryonic stem cells: current technologies and emerging industrial applications. Crit Rev Oncol Hematol 65: 54-80, 2008.
2. Arvanitis DA, Vafiadaki E, Fan GC, Mitton BA, Gregory KN, Del Monte F, Kontrogianni-Konstantopoulos A, Sanoudou D, Kranias EG. Histidine-rich Ca-binding protein interacts with sarcoplasmic reticulum Ca-ATPase. Am J Physiol Heart Circ Physiol 293: H1581-H1589, 2007.
3. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29, 2000.
4. Asp J, Steel D, Jonsson M, Ameen C, Dahlenborg K, Jeppsson A, Lindahl A, Sartipy P. Cardiomyocyte clusters derived from human embryonic stem cells share similarities with human heart tissue. J Mol Cell Biol 2: 276-283, 2010.
5. Beqqali A, Kloots J, Ward-van Oostwaard D, Mummery C, Passier R. Genome-wide transcriptional profiling of human embryonic stem cells differentiating to cardiomyocytes. Stem Cells 24: 1956-1967, 2006.
6. Berrebi-Bertrand I, Souchet M, Camelin JC, Laville MP, Calmels T, Bril A. Biophysical interaction between phospholamban and protein phosphatase 1 regulatory subunit GM. FEBS Lett 439: 224-230, 1998.
7. Binah O, Dolnikov K, Sadan O, Shilkrut M, Zeevi-Levin N, Amit M, Danon A, Itskovitz-Eldor J. Functional and developmental properties of human embryonic stem cells-derived cardiomyocytes. J Electrocardiol 40: S192-S196, 2007.
8. Cao F, Wagner RA, Wilson KD, Xie X, Fu JD, Drukker M, Lee A, Li RA, Gambhir SS, Weissman IL, Robbins RC, Wu JC. Transcriptional and functional profiling of human embryonic stem cell-derived cardiomyocytes. PLoS One 3: e3474, 2008.
9. Davies MP, An RH, Doevendans P, Kubalak S, Chien KR, Kass RS. Developmental changes in ionic channel activity in the embryonic murine heart. Circ Res 78: 15-25, 1996.
10. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: P3, 2003.
11. Dolnikov K, Shilkrut M, Zeevi-Levin N, Danon A, Gerecht-Nir S, Itskovitz-Eldor J, Binah O. Functional properties of human embryonic stem cell-derived cardiomyocytes. Ann NY Acad Sci 1047: 66-75, 2005.
12. 2+ handling and the role of sarcoplasmic reticulum in the contraction. Stem Cells 24: 236-245, 2006.
13. Gazzerro E, Sotgia F, Bruno C, Lisanti MP, Minetti C. Caveolinopathies: from the biology of caveolin-3 to human diseases. Eur J Hum Genet 18: 137-145, 2010.
14. Gupta MK, Illich DJ, Gaarz A, Matzkies M, Nguemo F, Pfannkuche K, Liang H, Classen S, Reppel M, Schultze JL, Hescheler J, Saric T. Global transcriptional profiles of beating clusters derived from human induced pluripotent stem cells and embryonic stem cells are highly similar. BMC Dev Biol 10: 98, 2010.
15. Itzhaki I, Rapoport S, Huber I, Mizrahi I, Zwi-Dantsis L, Arbel G, Schiller J, Gepstein L. Calcium handling in human induced pluripotent stem cell derived cardiomyocytes. PLoS One 6: e18037, 2011.
16. Itzhaki I, Schiller J, Beyar R, Satin J, Gepstein L. Calcium handling in embryonic stem cell-derived cardiac myocytes: of mice and men. Ann NY Acad Sci 1080: 207-215, 2006.
17. Jespersen T, Grunnet M, Olesen SP. The KCNQ1 potassium channel: from gene to physiological function. Physiology (Bethesda) 20: 408-416, 2005.
18. Jonsson MK, Duker G, Tropp C, Andersson B, Sartipy P, Vos MA, van Veen TA. Quantified proarrhythmic potential of selected human embryonic stem cell-derived cardiomyocytes. Stem Cell Res 4: 189-200, 2010.
19. Kim K, Zhang S, Jiang K, Cai L, Lee IB, Feldman LJ, Huang H. Measuring similarities between gene expression profiles through new data transformations. BMC Bioinformatics 8: 29, 2007.
20. Kita-Matsuo H, Barcova M, Prigozhina N, Salomonis N, Wei K, Jacot JG, Nelson B, Spiering S, Haverslag R, Kim C, Talantova M, Bajpai R, Calzolari D, Terskikh A, McCulloch AD, Price JH, Conklin BR, Chen HS, Mercola M. Lentiviral vectors and protocols for creation of stable hESC lines for fluorescent tracking and drug resistance selection of cardiomyocytes. PLoS One 4: e5046, 2009.
21. Kraus C, Rohde D, Weidenhammer C, Qiu G, Pleger ST, Voelkers M, Boerries M, Remppis A, Katus HA, Most P. S100A1 in cardiovascular health and disease: closing the gap between basic science and clinical therapy. J Mol Cell Cardiol 47: 445-455, 2009.
22. Leuner K, Kazanski V, Muller M, Essin K, Henke B, Gollasch M, Harteneck C, Muller WE. Hyperforin-a key constituent of St. John's wort specifically activates TRPC6 channels. FASEB J 21: 4101-4111, 2007.
23. Li GR, Sun HY, Chen JB, Zhou Y, Tse HF, Lau CP. Characterization of multiple ion channels in cultured human cardiac fibroblasts. PLoS One 4: e7307, 2009.
24. Liu J, Fu JD, Siu CW, Li RA. Functional sarcoplasmic reticulum for calcium handling of human embryonic stem cell-derived cardiomyocytes: insights for driven maturation. Stem Cells 25: 3038-3044, 2007.
25. 2+ handling properties of human embryonic stem cell-derived cardiomyocytes by calsequestrin expression. Am J Physiol Cell Physiol 297: C152-C159, 2009.
26. Mandenius CF, Steel D, Noor F, Meyer T, Heinzle E, Asp J, Arain S, Kraushaar U, Bremer S, Class R, Sartipy P. Cardiotoxicity testing using pluripotent stem cell-derived human cardiomyocytes and state-ofthe- art bioanalytics: a review. J Appl Toxicol 31: 191-205, 2011.
27. Marx SO, Reiken S, Hisamatsu Y, Jayaraman T, Burkhoff D, Rosemblit N, Marks AR. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101: 365-376, 2000.
28. Nalos L, Varkevisser R, Jonsson M, Houtman M, Beekman J, van der Nagel R, Thomsen M, Duker G, Sartipy P, de Boer T, Peschar M, Rook M, van Veen T, van der Heyden M, Vos M. Comparison of I(Kr) blocking drugs moxifloxacin, dofetilide E-4031 in five screening models of pro-arrhythmia reveals insufficient specificity of isolated cardiomyocytes. Br J Pharmacol 165: 467-478, 2011.
29. Norström A, Åkesson K, Hardarson T, Hamberger L, Björquist P, Sartipy P. Molecular and pharmacological properties of human embryonic stem cell-derived cardiomyocytes. Exp Biol Med (Maywood) 231: 1753-1762, 2006.
30. Ördog B, Brutyo E, Puskas LG, Papp JG, Varro A, Szabad J, Boldogkoi Z. Gene expression profiling of human cardiac potassium and sodium channels. Int J Cardiol 111: 386-393, 2006.
31. Rust W, Balakrishnan T, Zweigerdt R. Cardiomyocyte enrichment from human embryonic stem cell cultures by selection of ALCAM surface expression. Regen Med 4: 225-237, 2009.
32. Schlondorff JS, Pollak MR. TRPC6 in glomerular health and disease: what we know and what we believe. Semin Cell Dev Biol 17: 667-674, 2006.
33. 2+ stores and angiotensin-II/endothelin-1 signaling pathway are functional in human embryonic stem cell-derived cardiomyocytes. Stem Cells 26: 3130-3138, 2008.
34. Shanmugam M, Gao S, Hong C, Fefelova N, Nowycky MC, Xie LH, Periasamy M, Babu GJ. Ablation of phospholamban and sarcolipin results in cardiac hypertrophy and decreased cardiac contractility. Cardiovasc Res 89: 353-361, 2011.
35. Shippy R, Sendera TJ, Lockner R, Palaniappan C, Kaysser-Kranich T, Watts G, Alsobrook J. Performance evaluation of commercial shortoligonucleotide microarrays and the impact of noise in making crossplatform correlations. BMC Genomics 5: 61, 2004.
36. Shtilbans A, Choi SG, Fowkes ME, Khitrov G, Shahbazi M, Ting J, Zhang W, Sun Y, Sealfon SC, Lange DJ. Differential gene expression in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler 12: 250-256, 2011.
37. Snir M, Kehat I, Gepstein A, Coleman R, Itskovitz-Eldor J, Livne E, Gepstein L. Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes. Am J Physiol Heart Circ Physiol 285: H2355-H2363, 2003.
38. Synnergren J, Adak S, Englund MC, Giesler TL, Noaksson K, Lindahl A, Nilsson P, Nelson D, Abbot S, Olsson B, Sartipy P. Cardiomyogenic gene expression profiling of differentiating human embryonic stem cells. J Biotechnol 134: 162-170, 2008.
39. Synnergren J, Åkesson K, Dahlenborg K, Vidarsson H, Ameen C, Steel D, Lindahl A, Olsson B, Sartipy P. Molecular signature of cardiomyocyte clusters derived from human embryonic stem cells. Stem Cells 26: 1831-1840, 2008.
40. Synnergren J, Ameen C, Lindahl A, Olsson B, Sartipy P. Expression of microRNAs and their target mRNAs in human stem cell derived cardiomyocyte clusters and in heart tissue. Physiol Genomics 43: 581-594, 2010.
41. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121, 2001.
42. Vidarsson H, Hyllner J, Sartipy P. Differentiation of human embryonic stem cells to cardiomyocytes for in vitro and in vivo applications. Stem Cell Rev 6: 108-120, 2010.
43. von Mering C, Jensen LJ, Kuhn M, Chaffron S, Doerks T, Kruger B, Snel B, Bork P. STRING 7-recent developments in the integration and prediction of protein interactions. Nucleic Acids Res 35: D358-D362, 2007.
44. Xu XQ, Soo SY, Sun W, Zweigerdt R. Global expression profile of highly enriched cardiomyocytes derived from human embryonic stem cells. Stem Cells 27: 2163-2174, 2009.
45. Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J, Palecek SP, Thomson JA, Kamp TJ. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 104: e30-e41, 2009.